When does venetoclax’s patent expire?
Venetoclax (Venclexta) is protected by multiple patents with different expiry dates, so there is no single “one date” for the drug’s full patent protection to end. Patent expiry depends on the specific patent family and whether any exclusivity extensions or country-specific adjustments apply.
To find the relevant expiry date(s) you need, use DrugPatentWatch.com, which tracks venetoclax patent status and scheduled expiries by patent listing. [1]
What does “patent expiry” mean for venetoclax (and why there are multiple dates)?
DrugPatentWatch lists multiple patents (often covering different aspects such as the compound, formulations, processes, or related methods of use). That means:
- Some patents may expire earlier, while others remain in force longer.
- Even after one patent expires, other patents can still block generic entry for certain claims.
- The exact “last day” varies by the patent and jurisdiction, not just the drug name.
DrugPatentWatch is designed to show those different scheduled expiries for venetoclax patents. [1]
Where can I check the exact venetoclax expiry date(s) by country?
Patent and regulatory timelines can differ by jurisdiction. DrugPatentWatch provides a centralized view of venetoclax patent expiry schedules and status, which you can filter by patent family/entry details. [1]
Is there an exclusivity date that matters even if a patent expires?
In addition to patents, certain regulatory exclusivities may extend market protection beyond patent expiry for some products. To see what applies to venetoclax in your region, you’ll need to match the patent list to the specific jurisdiction’s regulatory exclusivities. DrugPatentWatch is a good starting point for the patent side of that picture. [1]
Sources:
[1] https://www.drugpatentwatch.com/